Florida surgeon general: Biden admin 'actively preventing' monoclonal antibody COVID-19 treatments
Those halted for distribution were made by drug companies Regeneron, Eli Lilly
The Facts Inside Our Reporter’s Notebook
Florida's surgeon general is accusing the Biden administration of "actively preventing the effective distribution of monoclonal antibody treatments" in the United States.
State Surgeon General Joseph Ladapo made the assertion in a letter Tuesday to Secretary of Health and Human Services Xavier Becerra following the administration recently pausing shipments of COVID-19 antibody treatments, arguing they are not effective against the omicron variant of the virus that recently emerged and spread swiftly across the world, according to Fox News.
Those halted for distribution were made by drug companies Regeneron and Eli Lilly. However, the federal government continues to supply Sotrovimab, a monoclonal antibody from the company Glaxosmithkline, which reportedly works against omicron.
Just News, No Noise
- Culture of corruption exposed in trial centering on ex-Illinois House Speaker
- Confronted by FBI abuses, Congress ready to add civil liberty protections to key surveillance law
- Blinken grilled about $4 billion in US funding for Ukrainian pensions at House hearing
- Kentucky’s Democrat governor vetoes bill banning gender transition surgeries for children
- College wants to fire professor for 'dishonesty' of different opinions